Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for December 13, 2018
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca initiated with a Buy at SunTrust
Dec 13, 2018 | 16:27 EDT
SunTrust analyst John Boris started AstraZeneca with a Buy rating and $48 price target.
News For AZN From the Last 2 Days
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
Apr 16, 2024 | 12:49 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
Apr 16, 2024 | 07:12 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
Apr 16, 2024 | 06:20 EDT